Report: Biotech revenue, spending on R&D rose in 2011

09/26/2012 | PharmaTimes (U.K.) · Pharmalot.com

Biotech companies, on average, generated $76 million in revenues last year, up 24% compared with 2010, according to a report from consulting firm BDO USA. On average, research and development spending grew to $50 million from about $47 million in 2010. Major biotechs with revenues surpassing $50 million reported a 33% increase in revenue, but smaller biotechs reported a 12% decline.

View Full Article in:

PharmaTimes (U.K.) · Pharmalot.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA